Hope emerging in the locally advanced cervical cancer landscape
-
Published:2024-09
Issue:
Volume:
Page:
-
ISSN:0140-6736
-
Container-title:The Lancet
-
language:en
-
Short-container-title:The Lancet
Author:
Gennigens Christine
Reference16 articles.
1. Proportions and incidence of locally advanced cervical cancer: a global systematic literature review;Monk;Int J Gynecol Cancer,2022
2. Optimal treatment in locally advanced cervical cancer;Gennigens;Expert Rev Anticancer Ther,2021
3. Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial;Oaknin;Lancet,2024
4. First-line pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer: final overall survival results of KEYNOTE-826;Monk;J Clin Oncol,2023